ABSTRACT
BACKGROUND: Post-traumatic stress disorder (PTSD) is a trauma-related disorder that is associated with pro-inflammatory activation and neurobiological impairments in the brain and leads to a series of affective-like behaviors. Electroacupuncture (EA) has been proposed as a clinically useful therapy for several brain diseases. However, the potential role of EA treatment in PTSD and its molecular and cellular mechanisms has rarely been investigated. METHODS: We used an established preclinical social defeat stress mouse model to study whether EA treatment modulates PTSD-like symptoms and understand its underlying mechanisms. To this end, male C57BL/6 mice were subjected to repeated social defeat stress (RSDS) for 6 consecutive days to induce symptoms of PTSD and treated with EA at Baihui (GV 20) and Dazhui (GV 14) acupoints. RESULTS: The stimulation of EA, but not needle insertion at Baihui (GV 20) and Dazhui (GV 14) acupoints effectively improved PTSD-like behaviors such as, social avoidance and anxiety-like behaviors. However, EA stimulation at the bilateral Tianzong (SI11) acupoints did not affect the PTSD-like behaviors obtained by RSDS. EA stimulation also markedly inhibited astrocyte activation in both the dorsal and ventral hippocampi of RSDS-treated mice. Using next-generation sequencing analysis, our results showed that EA stimulation attenuated RSDS-enhanced lipocalin 2 expression in the hippocampus. Importantly, using double-staining immunofluorescence, we observed that the increased lipocalin 2 expression in astrocytes by RSDS was also reduced by EA stimulation. In addition, intracerebroventricular injection of mouse recombinant lipocalin 2 protein in the lateral ventricles provoked social avoidance, anxiety-like behaviors, and the activation of astrocytes in the hippocampus. Interestingly, the overexpression of lipocalin 2 in the brain also altered the expression of stress-related genes, including monoamine oxidase A, monoamine oxidase B, mineralocorticoid receptor, and glucocorticoid receptor in the hippocampus. CONCLUSIONS: This study suggests that the treatment of EA at Baihui (GV 20) and Dazhui (GV 14) acupoints improves RSDS-induced social avoidance, anxiety-like behaviors, astrocyte activation, and lipocalin 2 expression. Furthermore, our findings also indicate that lipocalin 2 expression in the brain may be an important biomarker for the development of PTSD-related symptoms.
Subject(s)
Acupuncture Therapy , Anxiety/prevention & control , Electroacupuncture , Hippocampus/metabolism , Lipocalin-2/physiology , Social Defeat , Social Interaction , Stress Disorders, Post-Traumatic/therapy , Actins/biosynthesis , Actins/genetics , Acupuncture Points , Animals , Anxiety/etiology , Elevated Plus Maze Test , Exploratory Behavior , Injections, Intraventricular , Lipocalin-2/biosynthesis , Lipocalin-2/genetics , Lipocalin-2/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Monoamine Oxidase/biosynthesis , Monoamine Oxidase/genetics , Receptors, Glucocorticoid/biosynthesis , Receptors, Glucocorticoid/genetics , Receptors, Mineralocorticoid/biosynthesis , Receptors, Mineralocorticoid/genetics , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Stress Disorders, Post-Traumatic/etiology , Stress Disorders, Post-Traumatic/psychologyABSTRACT
Chemoresistance is a major cause of cancer progression and the mortality of cancer patients. Developing a safe strategy for enhancing chemosensitivity is a challenge for biomedical science. Recent studies have suggested that vitamin D supplementation may decrease the risk of many cancers. However, the role of vitamin D in chemotherapy remains unknown. We found that vitamin D sensitised oral cancer cells to cisplatin and partially reversed cisplatin resistance. Using RNA-seq, we discovered that lipocalin 2 (LCN2) is an important mediator. Cisplatin enhanced the expression of LCN2 by decreasing methylation at the promoter, whereas vitamin D enhanced methylation and thereby inhibited the expression of LCN2. Overexpression of LCN2 increased cell survival and cisplatin resistance both in vitro and in vivo. High LCN2 expression was positively associated with differentiation, lymph node metastasis, and T staging and predicted a poor prognosis in oral squamous cell carcinoma (OSCC) patients. LCN2 was also associated with post-chemotherapy recurrence. Moreover, we found that LCN2 promoted the activation of NF-κB by binding to ribosomal protein S3 (RPS3) and enhanced the interaction between RPS3 and p65. Our study reveals that vitamin D can enhance cisplatin chemotherapy and suggests that vitamin D should be supplied during chemotherapy; however, more follow-up clinical studies are needed.
Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Squamous Cell/diet therapy , Cisplatin/pharmacology , Dietary Supplements , Lipocalin-2/metabolism , Mouth Neoplasms/diet therapy , NF-kappa B/metabolism , Ribosomal Proteins/metabolism , Vitamin D/therapeutic use , Adult , Animals , Antineoplastic Agents/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cisplatin/therapeutic use , Drug Resistance, Neoplasm/drug effects , Female , Follow-Up Studies , Humans , Lipocalin-2/antagonists & inhibitors , Lipocalin-2/genetics , Male , Mice, Inbred BALB C , Mice, Nude , Mouth Neoplasms/drug therapy , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Receptors, Calcitriol/genetics , Ribosomal Proteins/genetics , Signal Transduction/drug effects , Transfection , Tumor Burden/drug effects , Vitamin D/pharmacology , Xenograft Model Antitumor AssaysABSTRACT
AIM: Renal toxicity of adefovir disoproxil (ADV) and tenofovir disoproxil fumarate (TDF) is a significant concern in chronic hepatitis B (CHB) patients. Early observational clinical data suggested that telbivudine (LdT) might have renoprotective effects. METHODS: In this prospective study, consecutive CHB patients on combined lamivudine (LAM) + ADV/TDF were switched to LdT + ADV/TDF at recruitment and were followed up for 24 months. Estimated glomerular filtration rate (eGFR) was calculated with the modification of diet in renal disease equation. The effects of LdT on cell viability and expression of kidney injury or apoptotic biomarkers were investigated in cultured renal tubular epithelial cell line HK-2. RESULTS: Thirty-one patients (median age 55 years, 90.3% male) were recruited (54.8% TDF: 45.2% ADV). Serum HBV DNA was undetectable at all time points. Median eGFR was 70.2 (IQR 62.6-77.9) and 81.5 (IQR 63.6-99.1) mL/min/1.73 m2 at baseline and 24 months, respectively (p < 0.001). Downstaging of chronic kidney disease was observed in eight (25.8%) patients and was more common in ADV-treated compared to TDF-treated patients (7/8 vs. 1/17, p = 0.011; OR 16, 95% CI 1.643-155.766, p = 0.017). In vitro data showed that adding LdT to ADV or TDF was associated with improved cell viability and lower expression of injury and apoptotic biomarkers compared with ADV or TDF alone. Treatment was prematurely discontinued in four(12.9%) patients due to myalgia. CONCLUSIONS: Clinical and in vitro data suggest that LdT has renoprotective effects in patients on long-term ADV/TDF treatment. LdT may be considered as an adjuvant therapy in this special group of patients with renal impairment (NCT03778567).
Subject(s)
Adenine/analogs & derivatives , Antiviral Agents/therapeutic use , Glomerular Filtration Rate , Hepatitis B, Chronic/drug therapy , Organophosphonates/adverse effects , Renal Insufficiency, Chronic/metabolism , Telbivudine/therapeutic use , Tenofovir/adverse effects , Activating Transcription Factor 4/drug effects , Activating Transcription Factor 4/genetics , Adenine/adverse effects , Adenine/pharmacology , Antiviral Agents/pharmacology , Apoptosis/drug effects , Caspase 12/drug effects , Caspase 12/genetics , Cell Line , Cell Survival/drug effects , Endoplasmic Reticulum Chaperone BiP , Epithelial Cells , Female , Heat-Shock Proteins/drug effects , Heat-Shock Proteins/genetics , Hepatitis A Virus Cellular Receptor 1/drug effects , Hepatitis A Virus Cellular Receptor 1/genetics , Hepatitis B, Chronic/complications , Humans , In Vitro Techniques , Interleukin-18/genetics , Kidney Tubules , Lamivudine/pharmacology , Lipocalin-2/drug effects , Lipocalin-2/genetics , Male , Middle Aged , Organophosphonates/pharmacology , Prospective Studies , Protective Agents , Renal Insufficiency, Chronic/chemically induced , Renal Insufficiency, Chronic/complications , Severity of Illness Index , Tenofovir/pharmacologyABSTRACT
In the adult mammalian brain, newborn granule cells are continuously integrated into hippocampal circuits, and the fine-tuning of this process is important for hippocampal function. Thus, the identification of factors that control adult neural stem cells (NSCs) maintenance, differentiation and integration is essential. Here we show that the deletion of the iron trafficking protein lipocalin-2 (LCN2) induces deficits in NSCs proliferation and commitment, with impact on the hippocampal-dependent contextual fear discriminative task. Mice deficient in LCN2 present an increase in the NSCs population, as a consequence of a G0/G1 cell cycle arrest induced by increased endogenous oxidative stress. Of notice, supplementation with the iron-chelating agent deferoxamine rescues NSCs oxidative stress, promotes cell cycle progression and improves contextual fear conditioning. LCN2 is, therefore, a novel key modulator of neurogenesis that, through iron, controls NSCs cell cycle progression and death, self-renewal, proliferation and differentiation and, ultimately, hippocampal function.
Subject(s)
Discrimination, Psychological/physiology , Lipocalin-2/metabolism , Neurogenesis/physiology , Animals , Cell Differentiation/physiology , Cell Movement/physiology , Cell Proliferation/physiology , Dentate Gyrus/metabolism , Fear/physiology , Hippocampus/cytology , Hippocampus/metabolism , Lipocalin-2/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Neural Stem Cells/physiology , Neurogenesis/genetics , Neurons/cytology , Neurons/metabolismABSTRACT
BACKGROUND: Lipocalin-2 (Lcn2) is a multifunctional innate immune protein that exhibits antimicrobial activity by the sequestration of bacterial siderophores, regulates iron homeostasis, and augments cellular tolerance to oxidative stress. Studies in the murine model of colitis have demonstrated that Lcn2 deficiency exacerbates colitogenesis; however, the therapeutic potential of Lcn2 supplementation has yet to be elucidated. In light of its potential mucoprotective functions, we, herein, investigated whether expression of Lcn2 in the probiotic bacterium can be exploited to alleviate experimental colitis. METHODS: Murine Lcn2 was cloned into the pT1NX plasmid and transformed into Lactococcus lactis to generate L. lactis-expressing Lcn2 (Lactis-Lcn2) or the empty plasmid (Lactis-Con). Lactis-Lcn2 was characterized by immunoblot and enzyme-linked immunosorbent assay and tested for its antimicrobial efficacy on Escherichia coli. The capacity of Lactis-Lcn2 and Lactis-Con to withstand adverse conditions was tested using in vitro viability assays. Dextran sodium sulfate colitis model was used to investigate the colonization ability and therapeutic potential of Lactis-Lcn2 and Lactis-Con. RESULTS: Lcn2 derived from Lactis-Lcn2 inhibited the growth of E. coli and reduced the bioactivity of enterobactin (E. coli-derived siderophore) in vitro. Lactis-Lcn2 displayed enhanced tolerance to adverse pH, high concentration of bile acids, and oxidative stress in vitro and survived better in the inflamed gut than Lactis-Con. Consistent with these features, Lactis-Lcn2 displayed better mucoprotection against intestinal inflammation than Lactis-Con when administered into mice with dextran sulfate sodium-induced acute colitis. CONCLUSIONS: Our findings suggest that Lcn2 expression can be exploited to enhance the survivability of probiotic bacteria during inflammation, which could further improve its efficacy to treat experimental colitis.
Subject(s)
Colitis/prevention & control , Disease Models, Animal , Inflammation/prevention & control , Intestines/drug effects , Lactococcus lactis/physiology , Lipocalin-2/metabolism , Protective Agents/pharmacology , Animals , Colitis/chemically induced , Colitis/metabolism , Dextran Sulfate/toxicity , Ectopic Gene Expression , Female , Inflammation/metabolism , Intestinal Mucosa/metabolism , Intestines/microbiology , Lipocalin-2/genetics , Mice , Mice, Inbred C57BLABSTRACT
Mammalian siderophores are believed to play a critical role in maintaining iron homeostasis. However, the properties and functions of mammalian siderophores have not been fully clarified. In this study, we have employed Chrome Azurol S (CAS) assay which is a well-established method for bacterial siderophores study, to detect and quantify mammalian siderophores in urine samples. Our study demonstrates that siderophores in urine can be altered by diet, gut microbiota and inflammation. C57BL/6 mice, fed on plant-based chow diets which contain numerous phytochemicals, have more siderophores in the urine compared to those fed on purified diets. Urinary siderophores were up-regulated in iron overload conditions, but not altered by other tested nutrients status. Further, germ-free mice displayed 50% reduced urinary siderophores, in comparison to conventional mice, indicating microbiota biotransformation is critical in generating or stimulating host metabolism to create more siderophores. Altered urinary siderophores levels during inflammation suggest that host health conditions influence systemic siderophores level. This is the first report to measure urinary siderophores as a whole, describing how siderophores levels are modulated under different physiological conditions. We believe that our study opens up a new field in mammalian siderophores research and the technique we used in a novel manner has the potential to be applied to clinical purpose.
Subject(s)
Anemia, Iron-Deficiency/urine , Colitis/urine , Diet/adverse effects , Gastrointestinal Microbiome , Iron Overload/urine , Siderophores/urine , Vitamin A Deficiency/urine , Anemia, Iron-Deficiency/etiology , Anemia, Iron-Deficiency/immunology , Anemia, Iron-Deficiency/microbiology , Animals , Biomarkers/blood , Biomarkers/urine , Colitis/chemically induced , Colitis/immunology , Colitis/microbiology , Crosses, Genetic , Diet, High-Fat/adverse effects , Female , Germ-Free Life , Hemochromatosis Protein/genetics , Hemochromatosis Protein/metabolism , Iron Overload/etiology , Iron Overload/immunology , Iron Overload/microbiology , Lipocalin-2/genetics , Lipocalin-2/metabolism , Male , Mice, Inbred C57BL , Mice, Knockout , Salmonella Infections, Animal/immunology , Salmonella Infections, Animal/microbiology , Salmonella Infections, Animal/urine , Selenium/deficiency , Selenium/immunology , Selenium/poisoning , Vitamin A Deficiency/etiology , Vitamin A Deficiency/immunology , Vitamin A Deficiency/microbiologyABSTRACT
Tanshinone IIA is a diterpene extracted from Salvia miltiorrhiza, a popular and safe herb medicine that has been widely used in China and other Asian countries. Previous studies have demonstrated the pleiotropic effects of Tanshinone IIA on many disease treatments via its antitoxicity, anti-inflammation, anti-oxidative stress, as well as antifibrosis activities. However, its effect on acute kidney injury (AKI) has not been fully investigated. Here, we show for the first time that systemic administration of Tanshinone IIA can lead to improved kidney function in folic acid-induced kidney injury mice. In the acute phase of AKI, Tanshinone IIA attenuated renal tubular epithelial injury, as determined by histologic changes and the detection of Neutrophil gelatinase-associated lipocalin (NGAL) in the kidney and urine. Additionally, Tanshinone IIA treatment resulted in elevated proliferating cell nuclear antigen (PCNA) expression and decreased inflammatory cells infiltration as well as chemokine expression, suggesting that Tanshinone IIA promoted renal repair following AKI and inhibited local inflammatory response in the injured kidney. This led to decreased long-term fibrosis in the injured kidney, characterized by less accumulation of fibronectin and collagen I in tubulointerstitium. Taken together, these results suggest that Tanshinone IIA may represent a potential approach for AKI treatment.
Subject(s)
Abietanes/administration & dosage , Acute Kidney Injury/prevention & control , Drugs, Chinese Herbal/administration & dosage , Protective Agents/administration & dosage , Salvia miltiorrhiza/chemistry , Acute Kidney Injury/chemically induced , Acute Kidney Injury/genetics , Acute Kidney Injury/metabolism , Animals , Folic Acid , Humans , Kidney/drug effects , Kidney/metabolism , Lipocalin-2/genetics , Lipocalin-2/metabolism , Male , Mice , Mice, Inbred C57BL , Phytotherapy , Proliferating Cell Nuclear Antigen/genetics , Proliferating Cell Nuclear Antigen/metabolismABSTRACT
Iron is an essential transition metal ion for virtually all aerobic organisms, yet its dysregulation (iron overload or anemia) is a harbinger of many pathologic conditions. Hence, iron homeostasis is tightly regulated to prevent the generation of catalytic iron (CI) which can damage cellular biomolecules. In this study, we investigated the role of iron-binding/trafficking innate immune protein, lipocalin 2 (Lcn2, aka siderocalin) on iron and CI homeostasis using Lcn2 knockout (KO) mice and their WT littermates. Administration of iron either systemically or via dietary intake strikingly upregulated Lcn2 in the serum, urine, feces, and liver of WT mice. However, similarly-treated Lcn2KO mice displayed elevated CI, augmented lipid peroxidation and other indices of organ damage markers, implicating that Lcn2 responses may be protective against iron-induced toxicity. Herein, we also show a negative association between serum Lcn2 and CI in the murine model of dextran sodium sulfate (DSS)-induced colitis. The inability of DSS-treated Lcn2KO mice to elicit hypoferremic response to acute colitis, implicates the involvement of Lcn2 in iron homeostasis during inflammation. Using bone marrow chimeras, we further show that Lcn2 derived from both immune and non-immune cells participates in CI regulation. Remarkably, exogenous rec-Lcn2 supplementation suppressed CI levels in Lcn2KO serum and urine. Collectively, our results suggest that Lcn2 may facilitate hypoferremia, suppress CI generation and prevent iron-mediated adverse effects.
Subject(s)
Anemia, Iron-Deficiency/metabolism , Biocatalysis/drug effects , Inflammation/metabolism , Iron/metabolism , Iron/toxicity , Lipocalin-2/metabolism , Animals , Colitis/chemically induced , Colitis/metabolism , Dextran Sulfate , Iron/administration & dosage , Lipocalin-2/deficiency , Lipocalin-2/genetics , Mice , Mice, Inbred C57BL , Mice, KnockoutABSTRACT
OBJECTIVE: Our recent studies have shown that blood components, including haemoglobin and iron, contribute to hydrocephalus development and brain injury after intraventricular haemorrhage (IVH). The current study investigated the role of lipocalin 2 (LCN2), a protein involved in iron handling, in the ventricular dilation and neuroinflammation caused by brain injury in a mouse model of IVH. DESIGN: Female wild-type (WT) C57BL/6 mice and LCN2-deficient (LCN2-/-) mice had an intraventricular injection of haemoglobin, and control mice received an equivalent amount of saline. MRI was performed presurgery and postsurgery to measure ventricular volume and the brains were used for either immunohistochemistry or western blot. RESULTS: Ventricular dilation was observed in WT mice at 24â h after haemoglobin (25â mg/mL, 20â µL) injection (12.5±2.4 vs 8.6±1.5â mm3 in the control, p<0.01). Western blotting showed that LCN2 was significantly upregulated in the periventricular area (p<0.01). LCN2 was mainly expressed in astrocytes, whereas the LCN2 receptor was detected in astrocytes, microglia/macrophages and neurons. Haemoglobin-induced ventricle dilation and glia activation were less in LCN2-/- mice (p<0.01). Injection of high-dose haemoglobin (50â mg/mL) resulted in lower mortality in LCN2-/- mice (27% vs 86% in WT; p<0.05). CONCLUSIONS: Intraventricular haemoglobin caused LCN2 upregulation and ventricular dilation. Haemoglobin resulted in lower mortality and less ventricular dilation in LCN2-/- mice. These results suggest that LCN2 has a role in haemoglobin-induced brain injury and may be a therapeutic target for IVH.